stock.name

Cencora Inc.

COR

Market Cap$48.34B
Close$

Compare Cencora

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cencora Inc.Cencora Inc.25.90.82%205%0.25.2
marketMarket Avg59.61.27%31%6.41
FinanceFinance Avg9.81.95%13%2.71.6

Earnings Call Q1 2024

January 31, 2024 - AI Summary

Cencora reported strong first quarter results, with revenue up 15% year-over-year to over $72 billion and adjusted earnings per share up 21%.
The company raised its fiscal 2024 full year guidance, reflecting the strength of its business and opportunities in the pharmaceutical market.
Cencora's core pharmaceutical distribution business showed outsized operating income growth, driven by strong volumes, favorable pricing trends, and effective expense management.

Exclusive for Stockcircle Pro members

Sign upSign Up
$242.64

Current Fair Value

0.8% downside

Overvalued by 0.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$48.34 Billion
Enterprise Value$50.25 Billion
Dividend Yield$1.9876 (0.82%)
Earnings per Share$9.18
Beta0.06
Outstanding Shares199,481,993
Avg 30 Day Volume1,216,588

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio25.89
PEG102.02
Price to Sales0.18
Price to Book Ratio61.16
Enterprise Value to Revenue0.19
Enterprise Value to EBIT17.93
Enterprise Value to Net Income26
Total Debt to Enterprise0.1
Debt to Equity5.24

Revenue Sources

No data

ESG Score

No data

About CoreSite Realty Corporation

CEO: Paul Szurek